Home - Phaon scientific GmbH

Scientific Scope

Phaon aims at…
…increasing patient benefit through addressing medical need with selection of effective agents
… personalizing therapy through individualized, biomarker-driven treatments concepts that address breast cancer heterogeneity
… accelerating drug development through introduction of early study endpoints (including early biological signals and clinical efficacy endpoints)

Learn more

Scientific Research

Breast cancer …
… is the most common cancer among women and one in eight women will eventually be diagnosed with the disease.
… prognosis has improved steadily. However, yet 1 in 10 breast cancer patients die within 5 years after primary diagnosis
… is composed of several (molecularly distinct) subtypes. These subtypes require molecular, personalized and individualized treatment concepts.
… presents with a large number of molecular targets. An increasing number of substances warrant novel scientific approaches to individualized therapy

Learn more

Our Vision/Mission

Phaon scientific is a study development group offering a platform for professionals to discuss, promote, and perform research in the field of oncology.

Learn more

A study is as good as it's design.

Almost 70 % of clinical trials have been amended at least once. This shows that studies steadily grow in complexity.

First: Develop

We develop comprehensive and thorough trial concepts.

Non-core procedures consume about 20 % of the trial budget and can cause unnecessary work for site personnel and a burden on patients.

Then: Execute

We make sure that trial costs stay focused on essential aspects.

Studies become more complex and underlie more regulations.

Finalized and ready to publish: Let's spread knowledge.

Studies have reported that 70% of clinical trials are not published within the first two years after study completion.

Last Step: Publish

We ensure timely reporting and dissemination of study results.